List of Tables
Table 1. Global Anti-tumor Drug Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Cytotoxic Drugs
Table 3. Key Players of Non-cytotoxic Drugs
Table 4. Global Anti-tumor Drug Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Anti-tumor Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Anti-tumor Drug Market Size by Region (US$ Million), 2021–2026
Table 7. Global Anti-tumor Drug Market Share by Region (2021–2026)
Table 8. Global Anti-tumor Drug Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Anti-tumor Drug Market Share by Region (2027–2032)
Table 10. Anti-tumor Drug Market Trends
Table 11. Anti-tumor Drug Market Drivers
Table 12. Anti-tumor Drug Market Challenges
Table 13. Anti-tumor Drug Market Restraints
Table 14. Global Anti-tumor Drug Revenue by Players (US$ Million), 2021–2026
Table 15. Global Anti-tumor Drug Market Share by Players (2021–2026)
Table 16. Global Top Anti-tumor Drug Players by Tier (Tier 1, Tier 2, and Tier 3), based on Anti-tumor Drug Revenue, 2025
Table 17. Ranking of Global Top Anti-tumor Drug Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Anti-tumor Drug Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Anti-tumor Drug, Headquarters and Area Served
Table 20. Global Key Players of Anti-tumor Drug, Products and Applications
Table 21. Global Key Players of Anti-tumor Drug, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Anti-tumor Drug Market Size by Type (US$ Million), 2021–2026
Table 24. Global Anti-tumor Drug Revenue Market Share by Type (2021–2026)
Table 25. Global Anti-tumor Drug Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Anti-tumor Drug Revenue Market Share by Type (2027–2032)
Table 27. Global Anti-tumor Drug Market Size by Application (US$ Million), 2021–2026
Table 28. Global Anti-tumor Drug Revenue Market Share by Application (2021–2026)
Table 29. Global Anti-tumor Drug Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Anti-tumor Drug Revenue Market Share by Application (2027–2032)
Table 31. North America Anti-tumor Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Anti-tumor Drug Market Size by Country (US$ Million), 2021–2026
Table 33. North America Anti-tumor Drug Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Anti-tumor Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Anti-tumor Drug Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Anti-tumor Drug Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Anti-tumor Drug Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Anti-tumor Drug Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Anti-tumor Drug Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Anti-tumor Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Anti-tumor Drug Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Anti-tumor Drug Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Anti-tumor Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Anti-tumor Drug Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Anti-tumor Drug Market Size by Country (US$ Million), 2027–2032
Table 46. Roche Company Details
Table 47. Roche Business Overview
Table 48. Roche Anti-tumor Drug Product
Table 49. Roche Revenue in Anti-tumor Drug Business (US$ Million), 2021–2026
Table 50. Roche Recent Development
Table 51. Novartis Company Details
Table 52. Novartis Business Overview
Table 53. Novartis Anti-tumor Drug Product
Table 54. Novartis Revenue in Anti-tumor Drug Business (US$ Million), 2021–2026
Table 55. Novartis Recent Development
Table 56. Celgene Company Details
Table 57. Celgene Business Overview
Table 58. Celgene Anti-tumor Drug Product
Table 59. Celgene Revenue in Anti-tumor Drug Business (US$ Million), 2021–2026
Table 60. Celgene Recent Development
Table 61. Bristol-Myers Squibb Company Details
Table 62. Bristol-Myers Squibb Business Overview
Table 63. Bristol-Myers Squibb Anti-tumor Drug Product
Table 64. Bristol-Myers Squibb Revenue in Anti-tumor Drug Business (US$ Million), 2021–2026
Table 65. Bristol-Myers Squibb Recent Development
Table 66. Amgen Company Details
Table 67. Amgen Business Overview
Table 68. Amgen Anti-tumor Drug Product
Table 69. Amgen Revenue in Anti-tumor Drug Business (US$ Million), 2021–2026
Table 70. Amgen Recent Development
Table 71. Johnson & Johnson Company Details
Table 72. Johnson & Johnson Business Overview
Table 73. Johnson & Johnson Anti-tumor Drug Product
Table 74. Johnson & Johnson Revenue in Anti-tumor Drug Business (US$ Million), 2021–2026
Table 75. Johnson & Johnson Recent Development
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Anti-tumor Drug Product
Table 79. Pfizer Revenue in Anti-tumor Drug Business (US$ Million), 2021–2026
Table 80. Pfizer Recent Development
Table 81. Takeda Company Details
Table 82. Takeda Business Overview
Table 83. Takeda Anti-tumor Drug Product
Table 84. Takeda Revenue in Anti-tumor Drug Business (US$ Million), 2021–2026
Table 85. Takeda Recent Development
Table 86. Eli Lilly Company Details
Table 87. Eli Lilly Business Overview
Table 88. Eli Lilly Anti-tumor Drug Product
Table 89. Eli Lilly Revenue in Anti-tumor Drug Business (US$ Million), 2021–2026
Table 90. Eli Lilly Recent Development
Table 91. AstraZeneca Company Details
Table 92. AstraZeneca Business Overview
Table 93. AstraZeneca Anti-tumor Drug Product
Table 94. AstraZeneca Revenue in Anti-tumor Drug Business (US$ Million), 2021–2026
Table 95. AstraZeneca Recent Development
Table 96. Astellas Company Details
Table 97. Astellas Business Overview
Table 98. Astellas Anti-tumor Drug Product
Table 99. Astellas Revenue in Anti-tumor Drug Business (US$ Million), 2021–2026
Table 100. Astellas Recent Development
Table 101. Merck & Co Company Details
Table 102. Merck & Co Business Overview
Table 103. Merck & Co Anti-tumor Drug Product
Table 104. Merck & Co Revenue in Anti-tumor Drug Business (US$ Million), 2021–2026
Table 105. Merck & Co Recent Development
Table 106. Sanofi Company Details
Table 107. Sanofi Business Overview
Table 108. Sanofi Anti-tumor Drug Product
Table 109. Sanofi Revenue in Anti-tumor Drug Business (US$ Million), 2021–2026
Table 110. Sanofi Recent Development
Table 111. Bayer Company Details
Table 112. Bayer Business Overview
Table 113. Bayer Anti-tumor Drug Product
Table 114. Bayer Revenue in Anti-tumor Drug Business (US$ Million), 2021–2026
Table 115. Bayer Recent Development
Table 116. Biogen Idec Company Details
Table 117. Biogen Idec Business Overview
Table 118. Biogen Idec Anti-tumor Drug Product
Table 119. Biogen Idec Revenue in Anti-tumor Drug Business (US$ Million), 2021–2026
Table 120. Biogen Idec Recent Development
Table 121. Eisai Company Details
Table 122. Eisai Business Overview
Table 123. Eisai Anti-tumor Drug Product
Table 124. Eisai Revenue in Anti-tumor Drug Business (US$ Million), 2021–2026
Table 125. Eisai Recent Development
Table 126. Teva Company Details
Table 127. Teva Business Overview
Table 128. Teva Anti-tumor Drug Product
Table 129. Teva Revenue in Anti-tumor Drug Business (US$ Million), 2021–2026
Table 130. Teva Recent Development
Table 131. Otsuka Company Details
Table 132. Otsuka Business Overview
Table 133. Otsuka Anti-tumor Drug Product
Table 134. Otsuka Revenue in Anti-tumor Drug Business (US$ Million), 2021–2026
Table 135. Otsuka Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
Table 139. Authors List of This Report
List of Figures
Figure 1. Anti-tumor Drug Picture
Figure 2. Global Anti-tumor Drug Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Anti-tumor Drug Market Share by Type: 2025 vs 2032
Figure 4. Cytotoxic Drugs Features
Figure 5. Non-cytotoxic Drugs Features
Figure 6. Global Anti-tumor Drug Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Anti-tumor Drug Market Share by Application: 2025 vs 2032
Figure 8. Alkylating Agents Case Studies
Figure 9. Anti-Metabolism Drugs Case Studies
Figure 10. Platinum Antineoplastic Agents Case Studies
Figure 11. Anthracycline Antitumor Drugs Case Studies
Figure 12. Microtubule Stabilizer Case Studies
Figure 13. Endocrine Therapy Drugs Case Studies
Figure 14. Immunotherapy Drugs Case Studies
Figure 15. Gene Therapy Drugs Case Studies
Figure 16. Targeted Antineoplastic Drugs Case Studies
Figure 17. Anti-tumor Drug Report Years Considered
Figure 18. Global Anti-tumor Drug Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 19. Global Anti-tumor Drug Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 20. Global Anti-tumor Drug Market Share by Region: 2025 vs 2032
Figure 21. Global Anti-tumor Drug Market Share by Players in 2025
Figure 22. Global Anti-tumor Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 23. The Top 10 and 5 Players Market Share by Anti-tumor Drug Revenue in 2025
Figure 24. North America Anti-tumor Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. North America Anti-tumor Drug Market Share by Country (2021–2032)
Figure 26. United States Anti-tumor Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Canada Anti-tumor Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Europe Anti-tumor Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Europe Anti-tumor Drug Market Share by Country (2021–2032)
Figure 30. Germany Anti-tumor Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. France Anti-tumor Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. U.K. Anti-tumor Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Italy Anti-tumor Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Russia Anti-tumor Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Ireland Anti-tumor Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Asia-Pacific Anti-tumor Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Asia-Pacific Anti-tumor Drug Market Share by Region (2021–2032)
Figure 38. China Anti-tumor Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Japan Anti-tumor Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. South Korea Anti-tumor Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Southeast Asia Anti-tumor Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. India Anti-tumor Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Australia & New Zealand Anti-tumor Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Latin America Anti-tumor Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Latin America Anti-tumor Drug Market Share by Country (2021–2032)
Figure 46. Mexico Anti-tumor Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Brazil Anti-tumor Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Middle East & Africa Anti-tumor Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Middle East & Africa Anti-tumor Drug Market Share by Country (2021–2032)
Figure 50. Israel Anti-tumor Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. Saudi Arabia Anti-tumor Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 52. UAE Anti-tumor Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 53. Roche Revenue Growth Rate in Anti-tumor Drug Business (2021–2026)
Figure 54. Novartis Revenue Growth Rate in Anti-tumor Drug Business (2021–2026)
Figure 55. Celgene Revenue Growth Rate in Anti-tumor Drug Business (2021–2026)
Figure 56. Bristol-Myers Squibb Revenue Growth Rate in Anti-tumor Drug Business (2021–2026)
Figure 57. Amgen Revenue Growth Rate in Anti-tumor Drug Business (2021–2026)
Figure 58. Johnson & Johnson Revenue Growth Rate in Anti-tumor Drug Business (2021–2026)
Figure 59. Pfizer Revenue Growth Rate in Anti-tumor Drug Business (2021–2026)
Figure 60. Takeda Revenue Growth Rate in Anti-tumor Drug Business (2021–2026)
Figure 61. Eli Lilly Revenue Growth Rate in Anti-tumor Drug Business (2021–2026)
Figure 62. AstraZeneca Revenue Growth Rate in Anti-tumor Drug Business (2021–2026)
Figure 63. Astellas Revenue Growth Rate in Anti-tumor Drug Business (2021–2026)
Figure 64. Merck & Co Revenue Growth Rate in Anti-tumor Drug Business (2021–2026)
Figure 65. Sanofi Revenue Growth Rate in Anti-tumor Drug Business (2021–2026)
Figure 66. Bayer Revenue Growth Rate in Anti-tumor Drug Business (2021–2026)
Figure 67. Biogen Idec Revenue Growth Rate in Anti-tumor Drug Business (2021–2026)
Figure 68. Eisai Revenue Growth Rate in Anti-tumor Drug Business (2021–2026)
Figure 69. Teva Revenue Growth Rate in Anti-tumor Drug Business (2021–2026)
Figure 70. Otsuka Revenue Growth Rate in Anti-tumor Drug Business (2021–2026)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
